Kirtland Hills Capital Management’s Idexx Laboratories IDXX Stock Holding History

Kirtland Hills Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Hold	764	–	–	0.11%	139
2026 Q1	$441K	Sell	764 -189	-20%	-$121K	0.14%	121
2025 Q4	$645K	Hold	953	–	–	0.23%	99
2025 Q3	$609K	Sell	953 -13	-1%	-$7.89K	0.24%	104
2025 Q2	$518K	Sell	966 -22	-2%	-$10.5K	0.24%	108
2025 Q1	$407K	Sell	988 -89	-8%	-$38.6K	0.25%	103
2024 Q4	$445K	Buy	1,077 +18	+2%	+$7.89K	0.29%	90
2024 Q3	$535K	Hold	1,059	–	–	0.3%	85
2024 Q2	$516K	Hold	1,059	–	–	0.43%	72
2024 Q1	$515K	Buy	+1,059	New	+$579K	0.44%	72

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Kirtland Hills Capital Management's IDXX Position: Q2 2026 in Review

Kirtland Hills Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 764 shares worth $402K. The position accounts for 0.11% of the portfolio, ranked #139.

Kirtland Hills Capital Management first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $645K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Kirtland Hills Capital Management held 764 shares of Idexx Laboratories worth $402K as of Q2 2026.
Kirtland Hills Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.11% of Kirtland Hills Capital Management's portfolio in Q2 2026, its #139 holding.
Kirtland Hills Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
Kirtland Hills Capital Management's Idexx Laboratories position peaked at $645K in Q4 2025.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.